Albion Financial Group’s Boston Scientific BSX Stock Holding History

Albion Financial Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.3K	Sell	662 -137	-17%	-$7.44K	﹤0.01%	335
2026 Q1	$50.1K	Buy	799 +137	+21%	+$11K	﹤0.01%	271
2025 Q4	$63.1K	Hold	662	–	–	﹤0.01%	238
2025 Q3	$64.6K	Hold	662	–	–	﹤0.01%	238
2025 Q2	$71.1K	Hold	662	–	–	﹤0.01%	215
2025 Q1	$66.8K	Hold	662	–	–	﹤0.01%	230
2024 Q4	$59.1K	Buy	662 +17	+3%	+$1.5K	﹤0.01%	239
2024 Q3	$54.1K	Hold	645	–	–	﹤0.01%	240
2024 Q2	$49.7K	Hold	645	–	–	﹤0.01%	242
2024 Q1	$44.2K	Buy	645 +110	+21%	+$7.07K	﹤0.01%	231
2023 Q4	$30.9K	Hold	535	–	–	﹤0.01%	251
2023 Q3	$28.2K	Hold	535	–	–	﹤0.01%	243
2023 Q2	$28.9K	Hold	535	–	–	﹤0.01%	250
2023 Q1	$26.8K	Hold	535	–	–	﹤0.01%	238
2022 Q4	$24.8K	Hold	535	–	–	﹤0.01%	243
2022 Q3	$21K	Sell	535 -61	-10%	-$2.45K	﹤0.01%	255
2022 Q2	$22K	Hold	596	–	–	﹤0.01%	262
2022 Q1	$26K	Sell	596 -61	-9%	-$2.64K	﹤0.01%	296
2021 Q4	$28K	Sell	657 -27	-4%	-$1.14K	﹤0.01%	327
2021 Q3	$30K	Hold	684	–	–	﹤0.01%	293
2021 Q2	$29K	Buy	+684	New	+$28.8K	﹤0.01%	298
2020 Q4	$25K	Buy	+684	New	+$24.7K	﹤0.01%	296

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Albion Financial Group's BSX Position: Q2 2026 in Review

Albion Financial Group reduced its Boston Scientific (BSX) stake by 17% in Q2 2026, selling an estimated $7.44K and leaving 662 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

Albion Financial Group first reported a position in BSX in Q4 2020 and has held it in 22 quarters since. The position peaked at $71.1K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Albion Financial Group held 662 shares of Boston Scientific worth $28.3K as of Q2 2026.
Albion Financial Group sold 137 Boston Scientific shares in Q2 2026, an estimated $7.44K.
Boston Scientific made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #335 holding.
Albion Financial Group first reported a position in Boston Scientific in Q4 2020 and has held it in 22 quarters since.
Albion Financial Group's Boston Scientific position peaked at $71.1K in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.